NCT03374007 Phase I Clinical Trial in Chinese Patients of Advanced and (or) Recurrent Solid Tumor/Lymphoma Status UNKNOWN Phase PHASE1
NCT03373526 Effects of Aerobic Training and Inspiratory Muscle Training in Patients During Hematopoietic Stem Cell Transplantation Status UNKNOWN Phase NA
NCT03361358 Pre-Screening Study to Identify MTAP Loss in Advanced Solid Tumors or Lymphoma Status COMPLETED Phase N/A
NCT03352765 A Phase I Study of Bendamustine and Melphalan Conditioning and Autologous Stem Cell Transplantation for Treatment of Multiple Myeloma and Relapsed/Refractory B-cell Lymphoma in Elderly Patients Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03344809 Enhancing Diagnosis in Chronic B-cell Lymphoproliferative Disorders Using Next-Generation Sequencing Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03336138 Application of Telemedicine to the Management of Aggressive Lymphomas Status COMPLETED Phase NA
NCT03330691 A Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03322384 UCDCC#271: Phase I/II Trial of Epacadostat, Intralesional SD101, Radiotherapy in Patients With Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT03314974 Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders Status RECRUITING Phase PHASE2
NCT03314922 A Study of INCB050465 in Japanese Subjects With Previously Treated B-Cell Lymphoma (CITADEL-111) Status COMPLETED Phase PHASE1
NCT03312205 CAR-T Cells for Relapsed or Refractory Haematopoietic and Lymphoid Malignancies Status UNKNOWN Phase PHASE1/PHASE2
NCT03311412 Sym021 Monotherapy, in Combination With Sym022 or Sym023, and in Combination With Both Sym022 and Sym023 in Patients With Advanced Solid Tumor Malignancies or Lymphomas Status COMPLETED Phase PHASE1
NCT03295240 The Study of Bendamustine, Rituximab, Ibrutinib, and Venetoclax in Relapsed, Refractory Mantle Cell Lymphoma Status COMPLETED Phase EARLY_PHASE1
NCT03283111 Correlation Analysis of T-lymphocyte Subsets and Prognosis in Autologous Stem Cell Transplantation (ASCT) for Lymphoma Status UNKNOWN Phase NA
NCT03271515 Immunotherapy With Bispecific CAR-T Cells for B-Cell Lymphoma, ALL and CLL Status UNKNOWN Phase PHASE1
NCT03269578 Sample Collection and Tracking for the Developmental Therapeutics Clinic Status RECRUITING Phase N/A